InsidersTradesSigma
Track the HLB생명과학 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, HLB생명과학 has logged 14 public disclosures. Market capitalisation: €381.8bn. The latest transaction was reported on 1 July 2026 (Other). Among the most active insiders: HLB. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
14 of 14 declarations
HLB Life Science is a company specializing in the healthcare and pharmaceutical sector, listed on the XKRX exchange. It focuses on developing innovative solutions for disease treatment.